Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceuticals crawled time : 14:20 save search
Deciphera Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 9, 2023
Published: 2023-08-02 (Crawled : 14:20) - biospace.com/
DCPH | $14.6 -0.48% -0.48% 320K
|
Health Technology
|
| O: -1.25%
H: 1.12%
C: -2.24%
conference pharmaceuticals financial results
Universe Pharmaceuticals INC Announces Share Consolidation
Published: 2023-07-27 (Crawled : 14:20) - globenewswire.com
UPC | $2.07 -5.91% -6.28% 35K
|
Manufacturing
|
| O: -0.09%
H: 14.36%
C: 6.42%
pharmaceuticals
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 17, 2023
Published: 2023-07-17 (Crawled : 14:20) - biospace.com/
EYPT | News | $16.47 -6.26% -6.68% 1.1M
|
Health Technology
|
| O: 1.19%
H: 4.77%
C: -0.81%
nasdaq pharmaceuticals grants
NovaBay Pharmaceuticals Reports Record Avenova Sales Day
Published: 2023-07-14 (Crawled : 14:20) - biospace.com/
NBY | $0.0773 0.39% 0.0% 920K
|
Health Technology
|
| O: 0.0%
H: 2.63%
C: -0.92%
day sales pharmaceuticals avenova
CNS Pharmaceuticals to Participate in the Virtual Investor Summer Spotlight Series
Published: 2023-07-05 (Crawled : 14:20) - biospace.com/
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: -2.69%
H: 4.6%
C: 3.23%
pharmaceuticals
NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023
Published: 2023-05-24 (Crawled : 14:20) - biospace.com/
NBY | $0.0773 0.39% 0.0% 920K
|
Health Technology
|
| O: -0.27%
H: 1.22%
C: -6.12%
conference pharmaceuticals growth
Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies with its Targeted Protein Degrader SP-3164
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
SLRX | $0.501 1.18% 19K
|
Commercial Services
|
| O: 2.25%
H: 0.55%
C: -1.65%
sp-3164 pharmaceuticals protein
TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
TFFP | $3.04 2.36% 2.3% 13K
|
Health Technology
|
| O: 7.02%
H: 5.54%
C: -2.07%
biosystems pharmaceuticals program funding
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
Published: 2022-05-03 (Crawled : 14:20) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: 17.94%
H: 2.52%
C: -5.18%
biotech pharmaceuticals
Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals
Published: 2022-07-18 (Crawled : 14:20) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 16.22%
H: 0.59%
C: -14.41%
xenleta pharmaceuticals therapeutics agreement
Theseus Pharmaceuticals Initial Dose Escalation Results from Ongoing Phase 1/2 Trial of THE-630 Accepted for Online Publication at 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 14:20) - prnewswire.com
THRX | $4.06 0.49% 0
|
|
| O: -0.62%
H: 11.18%
C: 9.73%
the-630 asco publication ongoing pharmaceuticals meeting trial results
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2023
Published: 2023-04-25 (Crawled : 14:20) - biospace.com/
ACAD | News | $16.57 -1.02% -1.03% 1.3M
|
Health Technology
|
| O: -0.05%
H: 0.84%
C: -0.1%
pharmaceuticals financial results
Salarius Pharmaceuticals Presents Compelling Data in Two SP-3164 Targeted Protein Degrader Posters at the American Association for Cancer Research Annual Meeting
Published: 2023-04-20 (Crawled : 14:20) - biospace.com/
SLRX | $0.501 1.18% 19K
|
Commercial Services
|
| O: -8.6%
H: 1.76%
C: -2.35%
sp-3164 association cancer pharmaceuticals research protein meeting
Acadia Pharmaceuticals to Present DAYBUE™ (trofinetide) Clinical Data and Rett Syndrome Real World Evidence at the 2023 American Academy of Neurology (AAN) Annual Meeting
Published: 2023-04-20 (Crawled : 14:20) - biospace.com/
ACAD | News | $16.57 -1.02% -1.03% 1.3M
|
Health Technology
|
| O: -0.15%
H: 2.08%
C: -0.1%
pharmaceuticals meeting rett syndrome
Aurinia Pharmaceuticals Announces New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis Issued by United States Patent and Trademark Office
Published: 2023-04-11 (Crawled : 14:20) - ir.auriniapharma.com
AUPH | $5.03 -1.18% -1.19% 790K
|
Health Technology
|
| O: 1.01%
H: 11.13%
C: 9.73%
lupkynis patent lupus treatment pharmaceuticals
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Published: 2023-04-06 (Crawled : 14:20) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.79%
H: 0.86%
C: 0.6%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 53.58%
H: 6.02%
C: -43.6%
approval berubicin treatment pharmaceuticals global trial
Tonix Pharmaceuticals Announces Poster Presentations at the American Association for Cancer Research Annual Meeting 2023
Published: 2023-04-05 (Crawled : 14:20) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 2.88%
H: 0.0%
C: 0.0%
TNXP | $0.1587 1.21% 1.2% 950K
|
Health Technology
|
| O: -0.07%
H: 5.37%
C: 4.04%
association cancer pharmaceuticals research meeting
Kiora Pharmaceuticals Reports 2022 Financial Results; Provides Update on Clinical Development Progress
Published: 2023-03-23 (Crawled : 14:20) - biospace.com/
KPRX | $0.504 -13.03% -14.98% 290K
|
Manufacturing
|
| O: 0.0%
H: 1.1%
C: -9.37%
update pharmaceuticals financial
Algernon Pharmaceuticals Announces Launch of Rights Offering
Published: 2023-03-21 (Crawled : 14:20) - biospace.com/
AGNPF | $0.089 178.69% 75K
|
Health Technology
|
| O: -4.08%
H: 0.0%
C: -8.74%
offering pharmaceuticals
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
Published: 2023-03-21 (Crawled : 14:20) - biospace.com/
ADIL | News | $1.72 1.18% 1.16% 140K
|
Health Technology
|
| O: 9.12%
H: 0.0%
C: -9.43%
ad04 alcohol group pharmaceuticals
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.